ED Visits for Cannabis Use Tied to Increased Risk for Incident Anxiety Disorder
By Lori Solomon HealthDay Reporter
TUESDAY, Feb. 13, 2024 -- Emergency department visits for cannabis use are associated with an increased three-year risk for having an incident health care visit for an anxiety disorder, according to a study published online Feb. 5 in eClinicalMedicine.
Daniel T. Myran, M.D., M.P.H., from the University of Ottawa in Ontario, Canada, and colleagues estimated the risk for having an incident health care visit for an anxiety disorder following an emergency department visit (January 2008 to March 2019) for cannabis use. The analysis included 34,822 individuals (aged 10 to 105 years) who had an incident emergency department visit due to cannabis.
The researchers found that within three years of an incident emergency department visit due to cannabis, 12.3 percent of individuals had an incident emergency department visit or hospitalization for an anxiety disorder versus 1.2 percent in the general population (adjusted hazard ratio [aHR], 3.69). Similar results were seen when further excluding individuals with prior outpatient care for anxiety disorders (aHR, 3.88) and across all age and sex strata. Younger men with emergency department visits for cannabis use had a greater risk relative to the general population than younger women with cannabis use (aHRs, 5.67 and 3.22, respectively).
"These findings have important clinical and policy implications given the increasing use of cannabis over time and trend towards legalization of cannabis," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
About One in Five Adults Experienced Anxiety, Depression in 2022
THURSDAY, Nov. 7, 2024 -- About one in five adults experienced any symptoms of anxiety and symptoms of depression during 2022, according to a study published online Nov. 7 in...
Anxiety/Depression Linked to HRQoL Losses in Seropositive RA
MONDAY, Nov. 4, 2024 -- Patients with seropositive rheumatoid arthritis (RA) with moderate and extreme anxiety/depression have mean health-related quality-of-life (HRQoL) losses...
Election Fears Are Compromising the Sleep Health of Americans
THURSDAY, Oct. 31, 2024 -- About 17 percent of all U.S. adults -- a striking 45 million Americans -- say the election has negatively impacted their sleep, according to a survey by...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.